Zydus launches Mirabegron ER Tablets in US market
Zydus Lifesciences announced the launch of Mirabegron Extended-Release Tablets, 25 mg in the US market. The company had earlier received final approval from the United...
Continue ReadingZydus Lifesciences announced the launch of Mirabegron Extended-Release Tablets, 25 mg in the US market. The company had earlier received final approval from the United...
Continue ReadingThe Directorate General of Foreign Trade (DGFT) has officially announced the discontinuation of safeguard measures on the import of isopropyl alcohol (IPA).The decision, communicated through...
Continue ReadingDr. Reddy’s Laboratories has introduced a condition-management programme for Irritable Bowel Syndrome (IBS).DailyBloom IBS is based on research and enabled by a mobile application developed...
Continue ReadingPharma major Cipla Ltd will acquire the cosmetics and personal care distribution and marketing business of Ivia Beaute Pvt Ltd, including the latter’s brands Astaberry,...
Continue ReadingLaurus Labs, once a leading manufacturer of antiretroviral (ARV) drugs, is undergoing yet another transformation under Satyanarayana Chava, its Founder & CEO. Until 2011, ARVs—a...
Continue ReadingDr Reddy’s Laboratories, a pharmaceutical company, launched Nerivio, its migraine management device in India last year. The company has now launched the device in Europe.Nerivio...
Continue ReadingBayer launched the patented drug vericiguat under the brand name Verquvo™ in India. VERQUVO™ (vericiguat) is the first soluble guanylate cyclase stimulator, a new class...
Continue ReadingMerck, Germany-based science and technology company, announced the appointment of Dhananjay Singh as the managing director of Merck Life Science in India, in addition to...
Continue ReadingBiocon Ltd. is pivoting to anti-obesity therapies as patents for the blockbuster medications start to expire, unleashing a wave of generic supply for the market...
Continue Reading